Filing Details
- Accession Number:
- 0001628280-16-020145
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-20 11:13:43
- Reporting Period:
- 2016-10-18
- Filing Date:
- 2016-10-20
- Accepted Time:
- 2016-10-20 11:13:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
771856 | Champions Oncology Inc. | CSBR | Biological Products, (No Disgnostic Substances) (2836) | 521401755 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1220630 | Joel Ackerman | C/O Champions Oncology, Inc. One University Place, Suite 307 Hackensack NJ 07601 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-10-18 | 1,000 | $1.70 | 1,043,266 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-10-18 | 201 | $1.69 | 1,043,467 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-10-18 | 381 | $1.69 | 1,043,848 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-10-18 | 418 | $1.70 | 1,044,266 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |